Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by lscfaon Feb 13, 2021 4:45pm
131 Views
Post# 32562814

RE:RE:RE:VM research paper. Very thorough

RE:RE:RE:VM research paper. Very thorough

"In November 2018, the company formed a 50/50 net revenue sharing JV (revenue less regulatory, marketing and sales costs) with Chief Medical Supplies Ltd. (“CMS”), named ImagingX Pharmaceuticals. CMS, headquartered in Calgary, Alberta, is a pharmaceutical manufacturing and distribution company, and primarily offers hemodialysis products to pharmacies and hospitals across Canada."

"VM is responsible to provide the API minerals, while CMS manufactures and bottles the end- products. Both entities will provide their products / services at no cost to the JV."

"Until VM is able to produce pharmaceutical grade barite from its own properties, the JV will source barite and iodine API from third parties. The first barite shipment, from a Chinese supplier, considered to be the only entity worldwide which is producing FDA / Health Canada approved natural pharmaceutical grade barite, was delivered to the JV in February 2019."

 



lscfa wrote:

The co. is outsourcing the manufacture of the product. Only thing left to do is market it to hospitals and imaging centers. 

 
"The JV will initially target Canada, and is currently awaiting approval on its first five products from Health Canada. Primary targets will be diagnostic imaging clinics and hospitals, and products will be sold to wholesale distributors." 


 

 

CLSHboss wrote: The company doesn't have much money to do anything.  That's why the SP has been asleep for so long.  They can't do much with the health Canada approval without any money.

they're operating on gas fumes..

 

 



<< Previous
Bullboard Posts
Next >>